Tokyo Tape
Sign in
← CellSeed

Annual report

7776.TEDINET S100VGWL
Period2024-01-01 → 2024-12-31
Filed2025-03-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 92
MetricValuePeriodScopeSource row
Revenue¥193m2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥190m2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥162m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥199m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income−¥846m2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥698m2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income−¥848m2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥710m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥887m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥866m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥745m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥729m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥858m2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥846m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income (owners)−¥915m2021-01-01 → 2021-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥784m2020-01-01 → 2020-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥860m2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥847m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income−¥913m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥768m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥2.4bnat 2024-12-31StandaloneAssets
Total assets¥2.5bnat 2023-12-31StandaloneAssets
Total assets¥1.5bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥270mat 2024-12-31StandaloneLiabilities
Total liabilities¥301mat 2023-12-31StandaloneLiabilities
Net assets / equity¥2.2bnat 2024-12-31StandaloneNet assets
Net assets / equity¥2.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.5bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.6bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.1bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥2.2bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥2.1bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2022-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥931mat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.5bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥866m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥779m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥718m2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥817m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥701m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥18m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥56m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥62m2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥110m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥855m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥882m2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥397m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-25.722024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-29.432023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.182021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.082021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-55.312020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-54.192020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥62.1at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥68.08at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥47.26at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥56.44at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥57.43at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥93.85at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥95.7at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio88.5%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio86.9%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.0%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.2%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued34,666,419at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued31,459,019at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued17,759,419at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued16,008,319at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees38at 2024-12-31StandaloneNumber of employees
Employees35at 2023-12-31StandaloneNumber of employees
Employees30at 2022-12-31dStandaloneNumber of employees
Employees44at 2021-12-31dStandaloneNumber of employees
Employees40at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2024-01-01 → 2024-12-31¥16m
Reconciling Itemsreconcilingsegment assetsat 2024-12-31¥2.2bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-12-31−¥230m
Cell Sheet Regenerative Medicinereportable segmentemployeesat 2024-12-3122 pure
Cell Sheet Regenerative Medicinereportable segmentrevenue2024-01-01 → 2024-12-31¥1m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2024-01-01 → 2024-12-31¥1m
Cell Sheet Regenerative Medicinereportable segmentsegment assetsat 2024-12-31¥70m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2024-01-01 → 2024-12-31−¥596m
Laboratory Consumables And Equipmentreportable segmentcapex2024-01-01 → 2024-12-31¥2m
Laboratory Consumables And Equipmentreportable segmentemployeesat 2024-12-3111 pure
Laboratory Consumables And Equipmentreportable segmentrevenue2024-01-01 → 2024-12-31¥192m
Laboratory Consumables And Equipmentreportable segmentrevenue external2024-01-01 → 2024-12-31¥192m
Laboratory Consumables And Equipmentreportable segmentsegment assetsat 2024-12-31¥121m
Laboratory Consumables And Equipmentreportable segmentsegment profit2024-01-01 → 2024-12-31−¥21m
—segment totalcapex2024-01-01 → 2024-12-31¥2m
—segment totalrevenue2024-01-01 → 2024-12-31¥193m
—segment totalrevenue external2024-01-01 → 2024-12-31¥193m
—segment totalsegment assetsat 2024-12-31¥191m
—segment totalsegment profit2024-01-01 → 2024-12-31−¥616m
Reconciling Itemsreconcilingcapex2023-01-01 → 2023-12-31¥21m
Reconciling Itemsreconcilingsegment assetsat 2023-12-31¥2.3bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-12-31−¥197m
Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-12-31¥8m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-12-31¥8m
Cell Sheet Regenerative Medicinereportable segmentsegment assetsat 2023-12-31¥65m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-12-31−¥469m
Laboratory Consumables And Equipmentreportable segmentcapex2023-01-01 → 2023-12-31¥770,000
Laboratory Consumables And Equipmentreportable segmentdepreciation2023-01-01 → 2023-12-31¥8m
Laboratory Consumables And Equipmentreportable segmentrevenue2023-01-01 → 2023-12-31¥182m
Laboratory Consumables And Equipmentreportable segmentrevenue external2023-01-01 → 2023-12-31¥182m
Laboratory Consumables And Equipmentreportable segmentsegment assetsat 2023-12-31¥133m
Laboratory Consumables And Equipmentreportable segmentsegment profit2023-01-01 → 2023-12-31−¥32m
—segment totalcapex2023-01-01 → 2023-12-31¥770,000
—segment totaldepreciation2023-01-01 → 2023-12-31¥8m
—segment totalrevenue2023-01-01 → 2023-12-31¥190m
—segment totalrevenue external2023-01-01 → 2023-12-31¥190m
—segment totalsegment assetsat 2023-12-31¥198m
—segment totalsegment profit2023-01-01 → 2023-12-31−¥501m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 991
ItemContextValueUnit
Cash and cash equivalents (5-year summary)Prior2YearInstant_NonConsolidatedMember1072210000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant_NonConsolidatedMember2163292000JPY
Cash and cash equivalents (5-year summary)CurrentYearInstant_NonConsolidatedMember2134299000JPY
Number of employeesPrior4YearInstant_NonConsolidatedMember40
Number of employeesPrior3YearInstant_NonConsolidatedMember44
Number of employeesPrior2YearInstant_NonConsolidatedMember30
Number of employeesPrior1YearInstant_NonConsolidatedMember35
Number of employeesCurrentYearInstant_NonConsolidatedMember38
Average number of temporary workersPrior4YearInstant_NonConsolidatedMember－
Average number of temporary workersPrior3YearInstant_NonConsolidatedMember－
Average number of temporary workersPrior2YearInstant_NonConsolidatedMember－
Average number of temporary workersPrior1YearInstant_NonConsolidatedMember－
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember－
Total shareholder returnPrior4YearInstant_NonConsolidatedMember0.480
Total shareholder returnPrior3YearInstant_NonConsolidatedMember0.357
Total shareholder returnPrior2YearInstant_NonConsolidatedMember0.326
Total shareholder returnPrior1YearInstant_NonConsolidatedMember0.526
Total shareholder returnCurrentYearInstant_NonConsolidatedMember0.775
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.074
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.211
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.181
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.515
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.825
Number of employeesCurrentYearInstant_NonConsolidatedMember38
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember41.9
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember4.8
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember6349663JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24158-000LaboratoryConsumablesAndEquipmentReportableSegmentsMember11
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember22
Number of employeesCurrentYearInstant_NonConsolidatedMember_CorporateSharedMember5
Number of employeesCurrentYearInstant_NonConsolidatedMember38
Ratio of female employees in managerial positions metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.273
All employees calculated based on provisions of article714 item1 of ordinance for enforcement of act on childcare leave caregiver leave and other measures for the welfare of workers caring for children or other family members ratio of male employees taking childcare leave metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.000
All employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.855
Regular employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.855
Non regular employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember－
Research and development expenses research and development activitiesCurrentYearDuration573317000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E24158-000LaboratoryConsumablesAndEquipmentReportableSegmentsMember35488000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember537828000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration18367000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember34666419
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember34666419
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant34666419
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant34666419
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember3
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember32
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember102
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass